NCT05159700 2025-12-15A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid TumorsZhuhai Yufan Biotechnologies Co., LtdPhase 1 Active not recruiting39 enrolled